Rare Disease Treatment Checklist: 7 Things to Consider
Seven-step checklist to choose genetic therapies, use patient-derived models, confirm safety, and plan translation for rare diseases.
Seven-step checklist to choose genetic therapies, use patient-derived models, confirm safety, and plan translation for rare diseases.
Families facing rare genetic diseases fund research, build registries, use iPSCs and custom therapies when no approved treatment exists.
Small molecules give accessible symptom control; gene replacement targets genetic causes but brings higher cost and delivery risks.
Questions to ask before starting rare disease treatment—confirm genetic diagnosis, compare therapies, weigh risks and costs, and plan long-term follow-up.
Compare gene therapy and antisense oligonucleotides: DNA vs RNA targets, durable vs reversible effects, delivery methods, and best-use cases for rare genetic diseases.
A 5-step plan to pursue treatment for rare genetic diseases: confirm diagnosis, join advocacy groups, research repurposed drugs, explore personalized therapies, and prepare for trials.
Integrated omics plus AI improve rare-disease diagnosis and target ID, enabling personalized, combination therapies tested in patient-derived models.